Identification of microRNA signature in different pediatric brain tumors
Understanding pediatric brain tumor biology is essential to help on disease stratification, and to find novel markers for early diagnosis. MicroRNA (miRNA) expression has been linked to clinical outcomes and tumor biology. Here, we aimed to detect the expression of different miRNAs in different pediatric brain tumor subtypes to discover biomarkers for early detection and develop novel therapies. Expression of 82 miRNAs was detected in 120 pediatric brain tumors from fixed-formalin paraffin-embedded tissues, low-grade glioma, high-grade glioma, ependymoma, and medulloblastoma, using quantitative real-time PCR. Low-expression of miR-221, miR-9, and miR-181c/d and over-expression of miR-101, miR-222, miR-139, miR-1827, and miR-34c was found in medulloblastoma; low expression of miR-10a and over-expression of miR-10b and miR-29a in ependymoma; low expression of miR-26a and overexpression of miR-19a/b, miR-24, miR-27a, miR- 584, and miR-527 in low-grade glioma. Cox regression showed differential miRNA expression between responders and non-responders. The most specific were miR-10a and miR-29a low expression in LGG non-responders, miR-135a and miR-146b over-expression in ependymoma non-responders, and miR-135b overexpression in medulloblastoma non-responders. MicroRNAs are differentially expressed in subtypes of brain tumors suggesting that they may help diagnosis. A greater understanding of aberrant miRNA in pediatric brain tumors may support development of novel therapies.
| Errataetall: |
ErratumIn: Genet Mol Biol. 2018 Jul/Sept.;41(3):725. - PMID 30235393 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Genetics and molecular biology - 41(2018), 1 vom: 01. Jan., Seite 27-34 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tantawy, Marwa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 29.09.2020 published: Print-Electronic ErratumIn: Genet Mol Biol. 2018 Jul/Sept.;41(3):725. - PMID 30235393 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1590/1678-4685-GMB-2016-0334 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM283073713 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM283073713 | ||
| 003 | DE-627 | ||
| 005 | 20231225035542.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1590/1678-4685-GMB-2016-0334 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0943.xml |
| 035 | |a (DE-627)NLM283073713 | ||
| 035 | |a (NLM)29658967 | ||
| 035 | |a (PII)S1415-47572018000100027 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tantawy, Marwa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of microRNA signature in different pediatric brain tumors |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Genet Mol Biol. 2018 Jul/Sept.;41(3):725. - PMID 30235393 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Understanding pediatric brain tumor biology is essential to help on disease stratification, and to find novel markers for early diagnosis. MicroRNA (miRNA) expression has been linked to clinical outcomes and tumor biology. Here, we aimed to detect the expression of different miRNAs in different pediatric brain tumor subtypes to discover biomarkers for early detection and develop novel therapies. Expression of 82 miRNAs was detected in 120 pediatric brain tumors from fixed-formalin paraffin-embedded tissues, low-grade glioma, high-grade glioma, ependymoma, and medulloblastoma, using quantitative real-time PCR. Low-expression of miR-221, miR-9, and miR-181c/d and over-expression of miR-101, miR-222, miR-139, miR-1827, and miR-34c was found in medulloblastoma; low expression of miR-10a and over-expression of miR-10b and miR-29a in ependymoma; low expression of miR-26a and overexpression of miR-19a/b, miR-24, miR-27a, miR- 584, and miR-527 in low-grade glioma. Cox regression showed differential miRNA expression between responders and non-responders. The most specific were miR-10a and miR-29a low expression in LGG non-responders, miR-135a and miR-146b over-expression in ependymoma non-responders, and miR-135b overexpression in medulloblastoma non-responders. MicroRNAs are differentially expressed in subtypes of brain tumors suggesting that they may help diagnosis. A greater understanding of aberrant miRNA in pediatric brain tumors may support development of novel therapies | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Elzayat, Mariam G |e verfasserin |4 aut | |
| 700 | 1 | |a Yehia, Dina |e verfasserin |4 aut | |
| 700 | 1 | |a Taha, Hala |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genetics and molecular biology |d 2007 |g 41(2018), 1 vom: 01. Jan., Seite 27-34 |w (DE-627)NLM176605118 |x 1415-4757 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2018 |g number:1 |g day:01 |g month:01 |g pages:27-34 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1590/1678-4685-GMB-2016-0334 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2018 |e 1 |b 01 |c 01 |h 27-34 | ||